GLP-1 Cost 2026: Wegovy, Zepbound & Ozempic Prices ($25 to $1,350/mo)

Verified July 2026: GLP-1 medications, Wegovy, Zepbound, Ozempic, Mounjaro, and Foundayo, cost between $25 and $1,350 per month in the July price snapshot. With a manufacturer savings card + commercial insurance, eligible patients may pay $25/month for some brands, subject to program terms. Without insurance: Embody advertises compounded semaglutide from $79 on a selected plan, Enhance MD advertises $212/mo on the 12-month plan ($249/mo month-to-month) for compounded semaglutide or $99 first month ($280/mo after) for compounded tirzepatide, Foundayo starts at $149/mo at the 0.8 mg strength via LillyDirect, and Sprout Health starts at $199 first month ($249/mo after) for telehealth with both brand and compounded options plus a dedicated care coordinator. At a September 20 price check, Foundayo is $149 at 2.5 mg (promotion through December 31, 2026; regular $199) and $199 at 5.5 mg (promotion through December 31, 2026; regular $299) or $299 at 9 mg; 14.5 mg and 17.2 mg remain $299 only when refilled within 45 days, otherwise $349. The manufacturer-direct snapshot was re-checked in August: NovoCare listed the Wegovy pen at $199/month for the first two low-dose fills, then $349/month at standard strengths ($399 for HD) and pill from $149/month, prescription required and dose-dependent; LillyDirect listed Zepbound from $299/month, with higher-dose pricing under its stated refill terms. Eligible patients can pay $50 per monthly supply through the separate GLP-1 Bridge program, not ordinary Part D. Its covered formulations and authorization rules apply; Medicare lists the requirements.

Quick answer by scenario: Have commercial insurance that covers Wegovy/Zepbound/Foundayo → apply the savings card, pay $25/mo if eligible and within the offer terms. Uninsured and want a low advertised cash-pay entry → Embody (semaglutide from $79 on a selected plan) or Enhance MD (semaglutide $212/mo on a 12-month plan, $249 month-to-month). Uninsured and want a brand-name pill → Foundayo at $149/mo (lowest dose) via LillyDirect. Uninsured and want brand-name injectable → LillyDirect ($299/mo Zepbound) or NovoCare Wegovy ($199/mo for the first two low-dose fills, then $349/mo at standard strengths or $399 HD). Uninsured and want comprehensive clinical oversight → Sprout Health $199 first month, then $249/mo includes a dedicated care coordinator, published 12-15% body weight loss outcomes at 6 months, and an established 2022+ operating track record. Medicare beneficiary → the GLP-1 Bridge program may cover eligible weight-management use at $50/mo. Use our cost calculator to estimate your monthly spend, see all providers sorted by lowest price, or take the 60-second match quiz.

This guide breaks down every pricing option: brand-name list prices, manufacturer direct-to-consumer programs (LillyDirect, NovoCare), the new Foundayo oral pill (see all oral GLP-1 pills compared), compounded telehealth providers, savings cards, Medicare/Medicaid coverage, and how the savings structures actually work. All prices verified July 2026 against provider websites and manufacturer announcements. Sources: CMS GLP-1 Bridge Demonstration, Zepbound savings card terms, Wegovy savings offer, Foundayo savings card.

How Much Do GLP-1 Medications Cost Without Insurance?

List prices (what pharmacies charge before discounts) don't reflect what most people pay. Here's the full picture:

How Do GLP-1 Savings Cards Work?

Both major manufacturers offer significant savings cards. These are the most impactful way to reduce your cost if you have commercial insurance:

Novo Nordisk (Wegovy, Ozempic, Saxenda): If you have commercial insurance that covers your medication, savings cards can bring your copay down to $25 per fill, subject to eligibility and program terms. For cash-pay patients, NovoCare listed the Wegovy pen at $199/month for the first two low-dose fills, then $349/month at standard strengths ($399 for HD) and oral pill from $149/month when checked August 7, 2026; a prescription is required and pricing is dose-dependent. Novo's March 31 launch included separate multi-month Wegovy offers at $249 to $329/month for the injection and $249 to $289/month for the pill through participating partners. Those dated launch terms should not be substituted for the current manufacturer-direct floor. Text SAVE to 83757 for a digital savings card.

Eli Lilly (Zepbound, Mounjaro, Foundayo): Eligible commercially insured patients may qualify for copays as low as $25 per fill under each program's terms. If insurance does not cover Zepbound, its savings-card price may be $499/month. LillyDirect lists self-pay Zepbound from $299 to $449/month depending on dose and refill terms. For Foundayo, LillyDirect lists $149/month at 0.8 mg, $149 at 2.5 mg (promotion through December 31, 2026; regular $199), $199 at 5.5 mg (promotion through December 31, 2026; regular $299) or $299 at 9 mg, and $299 at 14.5 mg or 17.2 mg only when refilled within 45 days, otherwise $349. Check the current Foundayo savings-card terms and the medication-specific expiration and eligibility rules before relying on a copay figure.

Does Medicare Cover GLP-1 Medications?

CMS launched the separate Medicare GLP-1 Bridge on July 1, 2026. It is not a change to ordinary Part D's weight-loss exclusion:

• •Beneficiary copay: $50 per approved monthly supply, with separate clinic fees possible
• •The $50 does not count toward Part D's deductible or out-of-pocket limit
• •Includes Foundayo tablets, Wegovy injection/tablets and Zepbound KwikPen, not Zepbound single-dose pens or vials
• •Eligible drug-plan enrollment, clinical criteria at treatment initiation, excluded diagnoses and prior Part D-paid GLP-1 use all matter
• •Clinical thresholds: BMI 35+, or BMI 30+/27+ with only the specific CMS-listed conditions; meeting a threshold does not establish approval

The Bridge is scheduled through December 31, 2027. CMS says the planned 2027 Part D launch of BALANCE is not proceeding; future Part D implementation is a possibility, not confirmed permanent coverage. State Medicaid participation is a separate question. CMS's current Bridge timeline.

Does Insurance Cover GLP-1 Medications for Weight Loss?

Insurance coverage for GLP-1s is actually getting more restrictive for weight loss in 2026, despite growing demand:

• •8.5% of commercially insured people (16+ million) have no GLP-1 coverage for weight loss at all
• •The number of people without Wegovy coverage specifically increased 42% vs 2025, over 41 million without access
• •Major insurers including BCBS, Cigna, and UnitedHealthcare implemented new restrictions as of January 2026, mostly limiting coverage to Type 2 diabetes only
• •Most insurers still cover Ozempic/Mounjaro for diabetes, restrictions primarily hit weight-loss-only indications

How Much Do Telehealth GLP-1 Programs Cost?

Online telehealth providers often offer lower total costs by bundling consultation fees with medication, though what the bundle covers varies more than the headline suggests. Confirm whether the quote includes the consultation, medication, shipping and any required membership. Here's a sample of what platforms charge:

Compare the payment due, not just the monthly equivalent. bmiMD advertises compounded semaglutide at $159 for one month or $1,428 for 12 months and tirzepatide at $249 for one month or $2,148 for 12 months. The annual payments work out to $119/mo and $179/mo, respectively; they are not month-to-month rates. These public prices were checked September 26, 2026. Confirm the prescribed product, payment schedule and full quote before enrolling. The second pattern to watch is the promotional price with no deadline attached: SnagRx advertises $69/mo compounded semaglutide beside a countdown that is a standing feature of the page rather than a dated expiry, and its own terms refer to non-refundable medical consult fees its homepage does not mention, so read that as a medication floor and not a checkout total.

We rank 34 telehealth GLP-1 providers by price, see the full list sorted cheapest-first, or take the 60-second match quiz to find the best provider for your insurance, budget, and medication preference. For tirzepatide specifically, see our cheapest tirzepatide page. If you are pricing one platform in particular, our review breaks down how much Willow's GLP-1 program costs tier by tier, alongside its Trustpilot and BBB records. The cheapest advertised rate is only worth taking if the company behind it checks out, which is why we publish the underlying verification separately: the Trimi reviews and legitimacy check lays out what we could and could not confirm about the company behind one of the lowest annual-prepay rates we track.

A provider that does not publish a complete price cannot be compared as if its headline fee covers everything. Ask for the medication, program and shipping total before starting a paid intake.

Can You Use FSA or HSA for GLP-1 Medications?

GLP-1 medications are FSA and HSA eligible when prescribed for a documented medical condition (obesity, Type 2 diabetes, metabolic syndrome). This applies to all brand-name GLP-1s, compounded versions with a valid prescription, and in many cases the telehealth consultation fees as well. You'll need a valid prescription and medical documentation, purely cosmetic weight loss without a medical diagnosis may not qualify.

Does Medicaid Cover GLP-1 Medications?

As of January 2026, only 13 state Medicaid fee-for-service programs cover GLP-1s for obesity treatment, down from 16. California, New Hampshire, Pennsylvania, and South Carolina recently eliminated coverage. Michigan added strict requirements including morbid obesity classification and documented failure of other interventions.

Do not treat a national program announcement as confirmation of your state's benefits. Check the current state drug policy and managed-care plan for the exact indication and formulation. The CMS BALANCE page is the source for model participation updates, not a personal coverage decision.